In the BioHarmony Drug Report Database

"Preview" Icon

Taliglucerase alfa

Elelyso, Vpriv (taliglucerase alfa) is an enzyme pharmaceutical. Taliglucerase alfa was first approved as Elelyso on 2010-08-26. It is used to treat gaucher disease in the USA. It has been approved in Europe to treat gaucher disease.

 

Trade Name

 

Vpriv
 

Common Name

 

taliglucerase alfa
 

ChEMBL ID

 

CHEMBL1964120
 

Indication

 

gaucher disease
 

Drug Class

 

Enzymes

Image (chem structure or protein)

Taliglucerase alfa structure rendering